occurring through p53-dependent pathway (DONG 2003; BODE & DONG 2004) , but it can also induce apoptosis independently of p53 (MAHYAR-ROEMER & ROEMER 2001) . Resveratrol can modulate signal transduction pathways by the inhibitory effect on the activation of transcription factors such as NF-κB and AP1 (KUNDU & SURH 2004) . Resveratrol, as a selective inhibitor of cyclooxygenase 2 (COX-2), is also a strong inhibitor of the dioxygenase activity of lipoxygenase (LOX) (PINTO et al. 1999 ).
Many authors have described the effect of resveratrol in the prevention of cardiovascular diseases (so-called French paradox). Resveratrol modulates lipid metabolism, inhibits the oxidation of LDL and thrombocyte aggregation (PACE-ASCIAK et al. 1995) , and has a vasodilatation activity (FRE-MONT 2000; GUSMAN et al. 2001) . LIN and TSAI (1999) studied the balance between free oxygen radicals and endogenous antioxidants. This effect is connected with the cardioprotective action of resveratrol which results from the inhibition of the formation of the oxidised form of LDL (WU et al. 2001) .
In our work, we studied chemopreventive effects of resveratrol on the mutagenicity of three known mutagens, two indirect mutagens aflatoxin B 1 (AFB 1 ) and 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ), and a direct mutagen N-nitroso-N-methylurea (MNU), using the Ames test on Salmonella typhimurium and the micronucleus test on mice.
MATERIAL AND METHODS

Chemicals.
The following chemicals were used for both tests: AFB 1 (Alexis Corporation, USA), IQ (ICN Biomedicals, Inc., Germany), MNU (Sigma-Aldrich Co, Lousiana, USA), resveratrol (Sigma-Aldrich Co, Lousiana, USA). Chemicals were diluted with dimethyl sulfoxide (DMSO) (Sigma-Aldrich Co, Lousiana, USA).
Ames test. The Ames test with Salmonella typhimurium TA98 and TA100 (AMES 1971; AMES et al. 1975; ČERNÁ et al. 1989) was used for the evaluation of the antimutagenic effect of resveratrol in vitro.
The mutagenic substances were used in the following concentrations: AFB 1 in concentrations of 10 µg, 1 µg, and 0.1 µg per plate with both strains TA98 and TA100, IQ in concentrations of 0.1 µg, 0.01 µg, and 0.001 µg per plate with the strain TA98, in concentrations of 10 µg, 1 µg, and 0.1 µg with the strain TA100, MNU in concentrations of 1000 µg, 100 µg, and 10 µg only with the strain TA100 as these concentrations had no effect on the strain TA98. Each concentration of each mutagen was combined with four different concentrations of the antimutagen (300 µg, 30 µg, 3 µg, and 0.3 µg of resveratrol per plate). All chemicals were diluted with DMSO. For the metabolic activation, the S9 fraction of liver homogenate from laboratory rats induced by a mixture of polychlorinated biphenyls Delor was used (MARON & AMES 1983 In vivo experiments (bone marrow micronucleus test) were carried out on ten-week-old male Balb C mice, each weighing 22-26 g (purchased from BIOTEST, Konárovice, CZ). The animals were housed under controlled light regime of 12/12 h, temperature of 20 ± 2°C, relative humidity of 60 ± 10%, and complete air recirculation 10-14-times per hour. The animals were supplied with water ad libitum and were fed with a commercial granulated mixture for laboratory rodents. These animals were divided into groups of 10 mice each.
Micronucleus test. The mouse bone marrow micronucleus test was carried out according to SCHMID (1975) . An increased frequency of micronuclei in polychromatophilic erythrocytes in comparison with the control groups indicates that the substance tested induces chromosomal damage in nucleated erythrocytes in the bone marrow. A total of 1000 polychromatophilic erythrocytes were scored per animal by the same observer for evaluating the frequencies of micronucleated polychromatophilic erythrocytes. Each experiment was run three times. As the negative control, mice were treated orally by a 7% solution of DMSO. For statistical analysis, Student's t-test was used.
Substances tested. The following concentrations of mutagens were used for in vivo test: AFB 1 1 mg per kg of body weight (b.w.), IQ 20 mg/kg b.w., MNU 20 mg/kg b.w. Resveratrol was applied to mice at the dose of 5 mg/kg b.w. by the gavage for three sequential days. Carcinogens were applied in one dose on the third day. The controls received 7% DMSO. All of the substances (diluted with DMSO) were applied in volumes of 100 µl/10 g b.w.
RESULTS
Ames test
The results of the Ames test are summarised in Tables 1-3 . All results presented in tables are expressed also as percentage of inhibition of the mutagenic activity of a sample of mutagen with antimutagen in comparison with the mutagenic activity of the respective mutagen.
Resveratrol at concentrations of 30 and 300 µg per plate revealed to possess a remarkable and dose dependent antimutagenic effect against all concentrations of AFB 1 (10, 1, and 0.1 µg per plate) in both strains TA98 and TA100. The only exception was the concentration of 30 µg per plate of resveratrol in combination with 10 µg per plate of AFB 1 in TA100. This concentration, similarly as other lower doses of resveratrol in both strains, did not reduce the mutagenic activity of AFB 1 , except the lower resveratrol dose -3 µg per plate which significantly reduced the activity of 1 µg of AFB 1 in the strain TA100 (Table 1) .
A strong dose dependent effect of resveratrol was discovered also against the second indirect mutagen IQ used in concentrations of 0.1, 0.01, and 0.001 µg per plate with the strain TA98, and 10, 1, and 0.1 with TA100. In this case not only two highest resveratrol concentrations, but also the concentration of 3 µg per plate was antimuta- statistically significant difference of the sample with antimutagen and mutagen from the mutagen alone *P ≤ 0.05; ** P ≤ 0.01 SD -standard deviation genic and significantly decreased the activity of IQ ( Table 2 ). The lowest concentration of 0.3 µg per plate was effective only against 1 and 0.1 µg of IQ per plate with TA100. However, resveratrol was not effective against any of the tested concentrations of the direct mutagen MNU (Table 3) , the decrease of mutagenic activity was only insignificant, even with the highest dose of resveratrol.
Micronucleus test
In the controls treated with 7% DMSO no significant increase in the frequency of micronuclei was observed in comparison with the intact animals.
The numbers of micronuclei in the animals influenced by resveratrol alone did not differ from those of the control group. On oral application of the combination of resveratrol (3 times 5 mg/kg b.w.) and AFB 1 in one dose (1 mg/kg b.w.), the number of micronuclei in polychromatophilic erythrocytes was lower in a statistically significant degree in comparison with the laboratory mice treated with AFB 1 alone.
A similar effect appeared on the application of the IQ mutagen. Resveratrol (3 times 5 mg/kg b.w.) in combination with one dose of IQ (20 mg/kg b.w.) significantly reduced its mutagenic effect.
Similarly, the treatment of mice with the combination of the same doses of resveratrol and one dose of MNU (50 mg/kg b.w.) led to a significant reduction of the number of micronuclei in comparison with the number of micronuclei elicited by MNU alone. The results are presented in Table 4 . Control ( 
DISCUSSION
New information about chemoprotective effects of phytochemicals from the field of molecular biology and biochemistry increases the interest of scientists and clinicians in the chemoprevention of malignant diseases and stimulate significant progress in experimental genotoxicology (MORSE & STONER 1993; KELLOFF et al. 1996; METTLIN 1997) . Anticarcinogenic and antimutagenic activities of plant substances were proved by many authors in both in vitro and in vivo systems. BOYCE et al. (2004) found resveratrol to be potent in blocking the mutagenicity of the food-derived heterocyclic amins: 2-amino-1-methyl-6 phenylimidazol [4,5-b] pyridine (MeIQx) and 2-amino-3,8dimethylimidazo [4,5-f] quinoxaline (PhIP) in the Ames test and in chinese hamster V 79 cells. Also, in our previous experimental studies we demonstrated antimutagenic and immunomodulatory effects of some substances occuring in plants (ŠMERÁK et al. 2002) .
It is probable that multiple mechanisms including the effect on the metabolic activation of mutagens or the influence on detoxification enzymes and blocking DNA-adducts formation are involved in the antimutagenic effect of resveratrol.
It has previously been shown using the Ames assay that resveratrol can suppress the induction of mutations by 3-amino-1,4-dimethyl-5H-pyrido[4,3-b] indole (TRP-p-1) (UENOBE et al. 1997), N-methyl-N'-nitro-N-nitrosoguanidin (MNNG) (KIM et al. 2002) , or by methylmethansulphonate and benzopyrene (FU et al. 2004) .
In our experiments on Salmonella typhimurium, resveratrol revealed a much stronger effect on the mutagenicity of the indirect mutagens AFB 1 and IQ in comparison with the effect on the mutagenicity of the direct mutagen MNU. Our results support the fact that resveratrol is very active in the suppression of metabolising phase I enzymes (GUSMAN et al. 2001) and are in agreement with the results of BOYCE et al. (2004) who proved the antimutagenic effect of resveratrol on the mutagenicity of the indirect food mutagen MeIQx. It has been also stated that high concentrations of resveratrol can inhibit cellular proliferation (BOYCE et al. 2004) , but this was not detected in our experiments on prokaryotic cells. *significantly higher number of micronuclei as against the negative control (DMSO) **significantly higher number of micronuclei as against mutagen alone SD -standard deviation A significant decrease of the mutagenicity of all three mutagens, AFB 1 , IQ, and MNU, by resveratrol was detected in micronucleus test. Also FU et al. (2004) proved that resveratrol prevents cyclophosphamide-induced micronucleus formation in the dose dependent manner.
Diet (nutrition) may be considered as a very important factor influencing favourably pathophysiological processes in organism and may be a very effective factor in the prevention strategy against various diseases, including diseases with genotoxicological ethiology.
The study of chemoprotective effects of phytochemicals or the study of their interactions and knowledge of the mechanisms of their effect shoud lead us to a wider use of these substances as dietary supplements or as a part of functional foods in the prevention of many diseases including tumors.
